HUP0302041A2 - Lactobacillus casei alkalmazása immunstimuláló peptidkészítményekben - Google Patents

Lactobacillus casei alkalmazása immunstimuláló peptidkészítményekben

Info

Publication number
HUP0302041A2
HUP0302041A2 HU0302041A HUP0302041A HUP0302041A2 HU P0302041 A2 HUP0302041 A2 HU P0302041A2 HU 0302041 A HU0302041 A HU 0302041A HU P0302041 A HUP0302041 A HU P0302041A HU P0302041 A2 HUP0302041 A2 HU P0302041A2
Authority
HU
Hungary
Prior art keywords
lactobacillus casei
immunostimulatory peptides
food
product
immunostimulatory
Prior art date
Application number
HU0302041A
Other languages
English (en)
Inventor
Benjamin Bonavida
Eric Postaire
Original Assignee
Compagnie Gervais Danone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8850597&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0302041(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Compagnie Gervais Danone filed Critical Compagnie Gervais Danone
Publication of HUP0302041A2 publication Critical patent/HUP0302041A2/hu
Publication of HUP0302041A3 publication Critical patent/HUP0302041A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A találmány tárgya Lactobacillus casei fajhoz tartozó baktériumtörzsalkalmazása orálisan alkalmazható, patogén mikroorganizmus ellenispecifikus immunválasz kiváltására szolgáló készítmény előállítására.A szóban forgó patogén mikroorganizmus a légzőrendszer valamelykórokozója, egy vírus, amely lehet rhinovírus, RS vírusok myxovírusokvalamelyike. A készítmény élelmiszer vagy élelmiszer-kiegészítő,különösen erjesztett tejtermék, így joghurt. Ó
HU0302041A 2000-05-25 2001-04-27 Use of lactobacillus casei in immunostimulatory peptides HUP0302041A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0006679A FR2809312B1 (fr) 2000-05-25 2000-05-25 Utilisation de l. casei dans des compositions immunostimulantes
PCT/FR2001/001310 WO2001089541A1 (fr) 2000-05-25 2001-04-27 Utilisation de lactobacillus casei dans des peptides immunostimulantes

Publications (2)

Publication Number Publication Date
HUP0302041A2 true HUP0302041A2 (hu) 2003-09-29
HUP0302041A3 HUP0302041A3 (en) 2005-11-28

Family

ID=8850597

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302041A HUP0302041A3 (en) 2000-05-25 2001-04-27 Use of lactobacillus casei in immunostimulatory peptides

Country Status (28)

Country Link
US (1) US7604809B2 (hu)
EP (1) EP1283714B1 (hu)
JP (1) JP2003534284A (hu)
CN (1) CN1194707C (hu)
AR (1) AR028626A1 (hu)
AT (1) ATE332143T1 (hu)
AU (2) AU5643501A (hu)
BG (1) BG65884B1 (hu)
BR (1) BR0111135A (hu)
CA (1) CA2410350C (hu)
CZ (1) CZ303600B6 (hu)
DE (1) DE60121327T2 (hu)
DK (1) DK1283714T3 (hu)
EA (1) EA005081B1 (hu)
ES (1) ES2267763T3 (hu)
FR (1) FR2809312B1 (hu)
HK (1) HK1055898A1 (hu)
HR (1) HRP20020935A2 (hu)
HU (1) HUP0302041A3 (hu)
IL (1) IL152980A0 (hu)
MA (1) MA25760A1 (hu)
MX (1) MXPA02011636A (hu)
NO (1) NO332369B1 (hu)
PL (1) PL201801B1 (hu)
PT (1) PT1283714E (hu)
SK (1) SK18272002A3 (hu)
WO (1) WO2001089541A1 (hu)
ZA (1) ZA200209087B (hu)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
GB0009294D0 (en) 2000-04-15 2000-05-31 Sec Dep For The Home Departmen Improvements in and relating to analysis of DNA samples
US9610347B2 (en) * 2001-04-30 2017-04-04 Cortcontrol Vaccination response for immunodeficiency or high cortisol
CN1317385C (zh) * 2003-05-30 2007-05-23 上海光明乳业股份有限公司 干酪乳杆菌Bd－II菌株及其在降低血脂方面的应用
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
ATE361101T1 (de) * 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
ZA200705844B (en) * 2004-12-15 2008-09-25 Van Der Westhuzen Corne Floris Detoxifying and immunity-booster composition
EP1683425A1 (en) * 2005-01-21 2006-07-26 Compagnie Gervais Danone Use of a fermented milk containing L. Casei for the manufacture of a composition for the prevention or treatment of a delayed-type hypersensitivity reaction
ES2264368B1 (es) * 2005-02-11 2007-12-01 Francisco Exposito Mesa Complemento alimenticio o dietetico compuesto por productos procedentes del lisado de microorganismos.
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
AU2006253006B8 (en) 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
BRPI0716997B8 (pt) 2006-09-10 2021-05-25 Glycotope Gmbh proteína ou composição de moléculas de proteína, métodos para produção e uso da mesma
FR2912657B1 (fr) * 2007-02-16 2009-04-17 Gervais Danone Sa Utilisation de lactobacillus casei pour renforcer la protection induite par la vaccination anti-grippale.
WO2009021585A1 (en) * 2007-08-13 2009-02-19 Dsm Ip Assets B.V. Probiotic bacteria for rducing the occurence of symptoms of winter infections
WO2009067000A1 (en) * 2007-11-20 2009-05-28 N.V. Nutricia Composition with synbiotics
EP2119365B1 (de) 2008-05-13 2017-08-16 Glycotope GmbH Fermentationsprozess
US8741365B2 (en) * 2008-05-13 2014-06-03 Glycotope Gmbh Fermentation process
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2153837A1 (en) * 2008-08-14 2010-02-17 Compagnie Gervais Danone Compositions comprising Lactobacillus casei for improving resistance to common infectious diseases
FR2937252B1 (fr) * 2008-10-17 2011-05-20 Pf Medicament Association d'un extrait de sureau et d'une souche de l. paracasei.
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2011083354A1 (en) * 2010-01-08 2011-07-14 Compagnie Gervais Danone Lactobacilli with anti-oxidant action
US20130121976A1 (en) * 2010-03-12 2013-05-16 Agusti Montserrat Carreras Lactic Acid Bacteria for Coeliac Disease
CN105288616B (zh) * 2010-10-15 2018-10-19 科.汉森有限公司 免疫佐剂
EP2455092A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
CA2844543A1 (en) 2011-08-22 2013-02-28 Glycotope Gmbh Microorganisms carrying a tumor antigen
WO2014038929A1 (en) 2012-09-07 2014-03-13 N.V. Nutricia Probiotics for producing antiviral factors
CN117815404A (zh) 2018-05-18 2024-04-05 第一三共株式会社 抗-muc1抗体-药物缀合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05236872A (ja) * 1992-02-27 1993-09-17 Takanashi Nyugyo Kk 乳酸菌含有食品
JP4112021B2 (ja) * 1994-02-16 2008-07-02 明治乳業株式会社 乳酸菌を用いた免疫賦活剤
ATE173135T1 (de) * 1995-01-02 1998-11-15 Gervais Danone Co Milchsäureferment, und ihre verwendung zur herstellung von antidiarrhöeprodrukten
ES2349669T3 (es) * 1997-08-21 2011-01-10 New Zealand Dairy Board Bacterias del ácido láctico que incrementan la inmunidad.
US6699517B2 (en) * 1997-11-28 2004-03-02 Compagnie Gervais Danone Method for preparing food products by fermenting soy milk with streptococcus thermophilus
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
KR100324441B1 (ko) * 1999-02-08 2002-02-27 이은선 위염, 위궤양, 십이지장궤양 예방을 위한 식품

Also Published As

Publication number Publication date
HRP20020935A2 (en) 2005-02-28
NO332369B1 (no) 2012-09-03
MA25760A1 (fr) 2003-04-01
NO20025595D0 (no) 2002-11-21
AR028626A1 (es) 2003-05-14
DK1283714T3 (da) 2006-10-30
BR0111135A (pt) 2003-04-08
WO2001089541A1 (fr) 2001-11-29
PT1283714E (pt) 2006-11-30
IL152980A0 (en) 2003-06-24
FR2809312A1 (fr) 2001-11-30
MXPA02011636A (es) 2003-05-14
CA2410350A1 (fr) 2001-11-29
HK1055898A1 (en) 2004-01-30
EP1283714A1 (fr) 2003-02-19
ES2267763T3 (es) 2007-03-16
CN1194707C (zh) 2005-03-30
CN1430518A (zh) 2003-07-16
CZ303600B6 (cs) 2013-01-02
BG107299A (bg) 2003-07-31
AU2001256435B2 (en) 2006-06-29
BG65884B1 (bg) 2010-04-30
EP1283714B1 (fr) 2006-07-05
HUP0302041A3 (en) 2005-11-28
NO20025595L (no) 2003-01-22
DE60121327D1 (de) 2006-08-17
AU5643501A (en) 2001-12-03
PL358408A1 (en) 2004-08-09
PL201801B1 (pl) 2009-05-29
EA200201248A1 (ru) 2003-06-26
FR2809312B1 (fr) 2002-07-12
US20040029127A1 (en) 2004-02-12
CZ20024189A3 (cs) 2003-05-14
CA2410350C (fr) 2013-04-09
EA005081B1 (ru) 2004-10-28
JP2003534284A (ja) 2003-11-18
ATE332143T1 (de) 2006-07-15
DE60121327T2 (de) 2007-07-26
ZA200209087B (en) 2004-06-30
SK18272002A3 (sk) 2003-08-05
US7604809B2 (en) 2009-10-20

Similar Documents

Publication Publication Date Title
HUP0302041A2 (hu) Lactobacillus casei alkalmazása immunstimuláló peptidkészítményekben
HUP0200205A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
ATE164073T1 (de) Den darm kolonisierende laktobacillen
HK1090289A1 (en) Antiallergic composition
HUP0100428A2 (hu) Lactobacillus paracasei subsp. paracasei fajhoz tartozó baktériumtörzs, abból élelmiszeripari alkalmazás céljára előállított készítmények, valamint a baktériumtörzset tartalmazó termékek
UA93542C2 (ru) Штамм молочнокислых бактерий streptococcus thermophilus, который обеспечивает улучшенную текстуру ферментированных продуктов
PT1359816E (pt) Combinacao de probioticos
MY127895A (en) New lactic acid bacteria strains capable of preventing diarrhoea
SE0402406D0 (sv) Probiotic lactobacillus strains for improved vaginal health
IN2004MU00201A (hu)
JP2009232702A5 (hu)
RU2009134520A (ru) Применение lactobacillus casei для усиления защиты, индуцированной вакцинацией против гриппа
WO2001082711A3 (en) Lactic acid fermented food products
DE60115919T2 (de) Neuartige lactobacillus paracasei stämme
PT1131080E (pt) Seleccao e utilizacoes de estirpes de bacterias lacticas moduladoras da imunidade nao-especifica
AU2002362549A1 (en) Novel lactic acid bacteria of the genus lactococcus lactis and use thereof for preserving food products
WO2001064899A3 (de) Nukleotidsequenzen kodierend für proteine beteiligt an der biosynthese von l-serin, verbessertes verfahren zur mikrobiellen herstellung von l-serin sowie ein dazu geeigneter genetisch veränderter mikroorganismus
UA64347C2 (en) Strain of bacteria of lactobacillus acidophilus being used in the production of bacterial preparations for functional diary products
RU2007141278A (ru) Способ получения кисломолочных, ферментированных и неферментированных пищевых продуктов, заквасок, гигиенических и косметических средств, биологически активных добавок и бактерийных препаратов
AU5069500A (en) Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
RU2002118758A (ru) Штамм энтерококков Enterococcus faecium L-3 для изготовления лечебно-профилактических средств и продуктов питания лечебно-профилактического назначения
GEU20061256Y (en) Yoghurt
UA41491C2 (uk) Лікувально-профілактичний кисломолочний продукт
UA23320A (uk) Штам бактерій віfіdовастеrіuм lоnguм, який використовується у виробhицтві бактеріальhих препаратів та фермеhтоваhих молочhих продуктів
BG105453U (en) Probiotic food additive

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: COMPAGNIE GERVAIS DANONE, FR

Free format text: FORMER OWNER(S): COMPAGNIE GERVAIS DANONE, FR

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished